Toward Clinically Ready Foundation Models in Medical Image Analysis: Adaptation Mechanisms and Deployment Trade-offs
Organizations: James Cook University, 14-88 McGregor Rd, Smithfield, 4878, Queensland, Australia
Abstract
Foundation models (FMs) have demonstrated strong transferability across medical imaging tasks, yet their clinical utility depends critically on how pretrained representations are adapted to domain-specific data, supervision regimes, and deployment constraints. Prior surveys primarily emphasize architectural advances and application coverage, while the mechanisms of adaptation and their implications for robustness, calibration, and regulatory feasibility remain insufficiently structured. This review introduces a strategy-centric framework for FM adaptation in medical image analysis (MIA). We conceptualize adaptation as a post-pretraining intervention and organize existing approaches into five mechanisms: parameter-, representation-, objective-, data-centric, and architectural/sequence-level adaptation. For each mechanism, we analyze trade-offs in adaptation depth, label efficiency, domain robustness, computational cost, auditability, and regulatory burden. We synthesize evidence across classification, segmentation, and detection tasks, highlighting how adaptation strategies influence clinically relevant failure modes rather than only aggregate benchmark performance. Finally, we examine how adaptation choices interact with validation protocols, calibration stability, multi-institutional deployment, and regulatory oversight. By reframing adaptation as a process of controlled representational change under clinical constraints, this review provides practical guidance for designing FM-based systems that are robust, auditable, and compatible with clinical deployment.
Figures & tables
| Strategy | Adaptation Depth | Label Efficiency | Domain Robustness | Computational Cost | Deployment Risk |
| Full Fine-Tuning | High | Low–Moderate | Low–Moderate | High | High |
| Partial Fine-Tuning | Moderate | Moderate | Moderate | Moderate | Moderate |
| Parameter-Efficient Adaptation | Low | High | Moderate | Low–Moderate | Low–Moderate |
| RLA | Low–Moderate | Very High | High | High | Low–Moderate |
| OLA | Low–Moderate | High | Moderate–High | Moderate | Moderate |
| DCA | Indirect | High | Moderate | Moderate–High | Moderate–High |
| Strategy | Primary problem it addresses | Mechanism of improvement | Characteristic risk | Deployment implication |
| PLA | Domain mismatch in pretrained parameters | Realigns the backbone by updating weights directly, from global to localized adaptation | Global drift or insufficient plasticity, depending on adaptation depth | Must match adaptation depth to data diversity and available revalidation resources |
| RLA | Misaligned representation geometry | Reorganizes the feature space through self-supervised or alignment-based pre-adaptation | Shortcut invariances or overspecialized features that fail under shift | Strong candidate for low-label and cross-site settings, but requires robust OOD evaluation |
| OLA | Miscalibrated optimization behavior | Encodes desired invariances, separations, and structural priors in the loss function | Objective-induced bias that may suppress subtle or rare pathology | Best used when behavior needs regulation more than capacity expansion |
| DCA | Limited, imbalanced, or noisy supervision | Improves the effective training signal by altering data coverage, selection, or label quality | Bias amplification and distributional mis-specification | Shifts the burden of robustness from model design to data governance and audit |
| ASA | Structural mismatch between FM design and medical data geometry | Embeds task-relevant inductive bias through volumetric, multimodal, or sequence-aware computation | Hard-to-reverse architectural assumptions and elevated system complexity | Should be chosen early and justified by task structure, workflow, and inference constraints |
| Task | Dominant Clinical Failure Mode | Most Effective Adaptation Levers | Recommended Validation Probes |
| Classification | Miscalibration under shift; rare-class sensitivity collapse; overconfident false positives/negatives in long-tailed settings | Constrained PLA (PEFT or partial FT); OLA for calibration control; DCA for tail rebalancing; RLA for cross-site robustness | Worst-site performance; subgroup calibration (ECE); tail-class recall; external multi-institution validation; confidence-threshold stress testing |
| Segmentation | Boundary drift; spatial incoherence; instability in small lesions; geometric errors affecting downstream measurements | ASA (2D→3D or spatial priors); OLA (surface/topology-aware losses); RLA for volumetric alignment; limited PLA to reduce drift | Surface Dice; HD95; lesion-size stratification; cross-site boundary stability; clinician-in-the-loop prompt robustness (if applicable) |
| Detection / Localization | Silent false negatives in rare findings; sensitivity collapse under shift; foreground–background imbalance | RLA for stable feature geometry; OLA with imbalance-aware objectives; DCA (targeted sampling, active learning); cautious PLA | Lesion-size–stratified sensitivity; prevalence-conditioned recall; cross-scanner evaluation; false-negative auditing; external cohort validation |
| Failure mechanism | Typical cause during adaptation | Observable effect | Clinical consequence |
| Over-adaptation and catastrophic forgetting | Excessive parameter updates under limited or homogeneous supervision | Representational drift and reduced cross-site generalization | Performance degradation under external validation |
| Shortcut learning and spurious correlations | Reliance on acquisition artifacts, scanner signatures, or annotation conventions | High in-distribution accuracy but unstable cross-site performance | Clinically implausible predictions that exploit dataset bias |
| Domain leakage | Overlap between pretraining, adaptation, and evaluation datasets | Inflated benchmark performance | Unreliable estimates of clinical generalization |
| Multimodal hallucination | Overreliance on textual supervision or prompt conditioning | Semantically confident but image-inconsistent predictions | False diagnostic reasoning or unsupported clinical claims |
| Deployment scenario | Data availability | Recommended adaptation strategy | Rationale | Key risks to monitor |
| Data-rich single institution | Large labeled cohort | Partial fine-tuning or parameter-efficient adaptation | Allows domain alignment while preserving pretrained structure | Site-specific overfitting and representational drift |
| Data-sparse clinical setting | Limited labeled data | Self-supervised pre-adaptation + parameter-efficient updates | Improves feature alignment without overwriting transferable representations | Overfitting and calibration instability |
| Multi-institutional deployment | Heterogeneous acquisition protocols | Parameter-efficient or frozen-backbone inference | Localizes model modification and preserves cross-site robustness | Domain shift and shortcut learning |
| Regulated clinical deployment | Moderate labeled data | Parameter-isolated updates (e.g., adapters, LoRA) | Supports traceable modification and targeted validation | Validation scope and change management complexity |